Embrex Inovoject NXT

Zoetis' recombinant vectored vaccine Embrex Inovoject has improved application and program management of Marek’s disease, infectious bursal disease virus and Newcastle disease challenges in chickens, the company says, and that vaccination in ovo or at day of age with the recombinant vectored vaccines is effective at controlling these challenges. The Inovoject NXT system is the next-generation Embrex biodevice designed to help producers protect chicks from disease challenges through in ovo vaccination.